Working… Menu
Trial record 7 of 377 for:    LENALIDOMIDE AND Dexamethasone

Revlimid / All-Trans Retinoic Acid (ATRA) / Dexamethasone in Relapsed/Refractory Multiple Myeloma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01985477
Recruitment Status : Terminated (Terminated Phase I due to slow accrual without progression to Phase II.)
First Posted : November 15, 2013
Last Update Posted : September 14, 2016
Celgene Corporation
Information provided by (Responsible Party):
M.D. Anderson Cancer Center

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : September 2015
Actual Study Completion Date : September 2015